fda vaccine - Search News

News

HIV prevention drug lenacapavir approved by FDA

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

STAT · 6h

Gilead’s CEO on the approval of a powerful new drug to prevent HIV

Gilead's CEO says he's committed to making sure people around the world can get his firm's new HIV prevention shot Yeztugo.

USA TODAY on MSN · 18h

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

CDC, Vaccine and Flu Shots

CNN on MSN · 20h

CDC vaccine advisers to vote on thimerosal in flu shots at first meeting of new panel

A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for Disease Control and Prevention includes a discussion and vote on thimerosal in flu vaccines,

U.S. News & World Report · 23h

CDC's Vaccine Advisory Committee to Vote on RSV, Flu Shots

The U.S. Centers for Disease Control and Prevention panel of vaccine experts will vote on shots for respiratory syncytial virus and influenza at a meeting scheduled for June 25 and 26, according to the agency's website.

Bloomberg on MSN · 23h

RFK Jr.’s Vaccine Panel to Vote on Flu Shots With Mercury

A panel of key government advisers appointed by Health and Human Services Secretary Robert F. Kennedy Jr. will weigh in on an infrequently used vaccine preservative that has been wrongly linked to autism in the past.

2hon MSN

Revolutionary New Drug Offers 99.9% Protection Against HIV

The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high ...

5don MSN

FDA expands approval of Moderna's RSV vaccine to some adults under age 60

The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...

FDA Vaccine Advisor Calls For COVID Victims To Sue Trump Admin

Offit, who sits on the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC), made the comments after criticizing Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.

FDA clears Moderna’s RSV vaccine for use in people ages 18 to 59

The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...

6don MSN

US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults

The U.S. Food and Drug Administration on Thursday expanded the use of Moderna's respiratory syncytial virus vaccine to a ...

17hon MSN

RFK Jr.’s new vaccine advisers to discuss preservative wrongly linked to autism

A key vaccine advisory panel handpicked by Health and Human Services Secretary Robert F. Kennedy Jr. is set to vote on a vaccine ingredient wrongly linked to autism as part of its scaled-down ...

Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease

Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...

STAT6d

FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59

The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results